Spectral Capital Appoints Dr. Moshik Cohen as Chief Technology Officer
Spectral Capital (OTCQB: FCCN) has appointed Dr. Moshik Cohen as Chief Technology Officer to lead the company's technology roadmap. Dr. Cohen, an expert in plasmonics, nanophotonics, and quantum systems, will drive innovations in the company's Quantum Bridge approach, helping transition from classical to quantum computing architectures.
The appointment marks Spectral's transformation from a Quantum as a Service (QaaS) provider to a Deep-tech holding company focused on quantum computing IP. Dr. Cohen's expertise in plasmonics enables data transmission at near-light speed with minimal power consumption, featuring ultra-fast data transfer, energy efficiency, and room-temperature operation capabilities.
Spectral Capital (OTCQB: FCCN) ha nominato Dr. Moshik Cohen come Chief Technology Officer per guidare la roadmap tecnologica dell'azienda. Il Dr. Cohen, esperto in plasmonica, nanofotonica e sistemi quantistici, guiderà le innovazioni nell'approccio Quantum Bridge dell'azienda, facilitando la transizione da architetture di calcolo classico a quantum.
Questa nomina segna la trasformazione di Spectral da fornitore di Quantum as a Service (QaaS) a una holding di Deep-tech focalizzata sulla proprietà intellettuale nel campo del calcolo quantistico. L'expertise del Dr. Cohen nella plasmonica consente la trasmissione dati a velocità prossime a quella della luce, con un consumo energetico minimo, caratterizzandosi per un trasferimento dati ultra-veloce, efficienza energetica e capacità di funzionamento a temperatura ambiente.
Spectral Capital (OTCQB: FCCN) ha nombrado Dr. Moshik Cohen como Chief Technology Officer para liderar la hoja de ruta tecnológica de la empresa. El Dr. Cohen, experto en plasmonica, nanofotónica y sistemas cuánticos, impulsará las innovaciones en el enfoque Quantum Bridge de la empresa, facilitando la transición de arquitecturas de computación clásica a cuántica.
La designación marca la transformación de Spectral de proveedor de Quantum as a Service (QaaS) a una empresa holding de tecnología profunda centrada en la propiedad intelectual de la computación cuántica. La experiencia del Dr. Cohen en plasmonica permite la transmisión de datos a velocidad cercana a la luz con un consumo de energía mínimo, presentando transferencia de datos ultrarrápida, eficiencia energética y capacidades de operación a temperatura ambiente.
스펙트럴 캐피탈 (OTCQB: FCCN)은 Moshik Cohen 박사를 최고 기술 책임자로 임명하여 회사의 기술 로드맵을 이끌도록 하였습니다. Cohen 박사는 플라스모닉스, 나노포토닉스 및 양자 시스템 분야의 전문가로서, 회사의 양자 브리지 접근 방식에서 혁신을 불러일으키고 고전 컴퓨팅 아키텍처에서 양자 컴퓨팅 아키텍처로의 전환을 도울 것입니다.
이번 임명은 스펙트럴이 Quantum as a Service (QaaS) 제공업체에서 양자 컴퓨팅 지식 재산(IP)에 중점을 둔 딥 테크 지주 회사로 변모했음을 나타냅니다. Cohen 박사의 플라스모닉스 전문 지식은 최소한의 전력 소비로 빛의 속도에 가까운 데이터 전송을 가능하게 하며, 초고속 데이터 전송, 에너지 효율성 및 상온 작동 능력을 특징으로 합니다.
Spectral Capital (OTCQB: FCCN) a nommé Dr. Moshik Cohen en tant que Directeur Technique pour diriger la feuille de route technologique de l'entreprise. Le Dr. Cohen, expert en plasmonique, nanophotonique et systèmes quantiques, stimulera les innovations dans l'approche Quantum Bridge de l'entreprise, aidant à la transition des architectures de calcul classique vers le calcul quantique.
Cette nomination marque la transformation de Spectral d'un fournisseur de Quantum as a Service (QaaS) à une société de capital-risque Deep-tech axée sur la propriété intellectuelle en informatique quantique. L'expertise du Dr. Cohen en plasmonique permet la transmission de données à une vitesse proche de celle de la lumière avec une consommation d'énergie minimale, offrant un transfert de données ultra-rapide, une efficacité énergétique et des capacités de fonctionnement à température ambiante.
Spectral Capital (OTCQB: FCCN) hat Dr. Moshik Cohen zum Chief Technology Officer ernannt, um die technologische Roadmap des Unternehmens zu leiten. Dr. Cohen, ein Experte für Plasmonik, Nanophotonik und Quantensysteme, wird Innovationen im Quantum Bridge-Ansatz des Unternehmens vorantreiben und den Übergang von klassischen zu quantencomputing Architekturen unterstützen.
Die Ernennung markiert die Transformation von Spectral von einem Anbieter von Quantum as a Service (QaaS) zu einem Deep-Tech-Holdingunternehmen, das sich auf geistiges Eigentum im Bereich Quantencomputing konzentriert. Dr. Cohens Expertise in der Plasmonik ermöglicht die Datenübertragung nahezu mit Lichtgeschwindigkeit bei minimalem Stromverbrauch und bietet ultra-schnelle Datenübertragung, Energieeffizienz und Betriebsmöglichkeiten bei Raumtemperatur.
- Appointment of globally recognized expert in plasmonics and quantum systems
- Strategic transformation from QaaS to Deep-tech holding company
- Access to advanced plasmonic technology enabling near-light speed data transmission
- Technology advantages including low power consumption and room-temperature operation
- None.
"Dr. Moshik Cohen is a visionary leader whose groundbreaking research in plasmonics and deep technology and semiconductor experience has reshaped what's possible in making practical strides in transfer and computation," said Sean Michael Brehm, Chairman of Spectral Capital. "With his expertise, Spectral is transforming itself from a Quantum as a Service Company (QaaS) to a Deep-tech holding company with the world's most practical IP in Quantum Computing.
Leading Expertise in Plasmonics and Nanophotonics
Plasmonics, the study of light-induced electron waves on nanoscale metal surfaces, enables data transmission at near-light speed while operating with minimal power consumption. Dr. Cohen's pioneering work has demonstrated plasmonic technologies that can significantly enhance classical computing systems:
- Ultra-Fast Data Transfer: Achieving speeds approaching the speed of light.
- Energy Efficiency: Operating at low power with reduced heat generation.
- Room-Temperature Operation: Practical advancements for real-world applications.
With more than two decades of experience spanning cutting-edge research and commercialization, Dr. Cohen has consistently delivered scalable, high-impact solutions across industries, including telecommunications, autonomous systems, and quantum technologies.
About Dr. Moshik Cohen
Dr. Cohen holds a PhD in Physical Electronics and has led groundbreaking research in plasmonics, nanophotonics, and quantum systems. His contributions have been featured in Nature, Science, and other top-tier scientific journals, advancing global understanding of how plasmonic technologies can unlock near-light-speed computing.
Prior to joining Spectral, Dr. Cohen held leadership roles at globally recognized organizations:
- Wisense Technologies: Founder and CEO, leading innovations in imaging radar and advanced sensors for autonomous systems.
- Samsung Electronics: Director of R&D, developing neuromorphic processors and AI-driven systems.
- Israel Aerospace Industries (IAI): Group Lead, advancing autonomous and defense technologies.
- Intel Corporation: Driving innovations in millimeter-wave RFICs and phased-array antennas for next-generation communication systems.
"Spectral's vision for a new era of computing aligns perfectly with the potential of plasmonics," said Dr. Moshik Cohen. "We are on the cusp of enabling classical systems to achieve near-quantum-level speeds. I look forward to leading Spectral's technical innovation and delivering solutions that will transform industries and pave the way for practical quantum computing."
Positioned for Transformation
Under Dr. Cohen's leadership, Spectral is enhancing its commitment to deep-tech innovation and scalable solutions that redefine classical computing. Leveraging expertise in plasmonics and advanced quantum systems, Spectral continues to explore strategic opportunities that align with its mission to deliver the next generation of speed and efficiency in data transmission and computation. "With decades of groundbreaking research, Dr. Cohen has proven his ability to turn visionary ideas into practical scalable solutions," said Jenifer Osterwalder, CEO of Spectral Capital. "His work will accelerate Spectral's current Quantum Bridge initiative and deliver next-generation technologies that redefine speed, efficiency, and scalability while connecting classical compute to emerging quantum systems."
The Company will be providing further updates on Spectral's advancements, and a technological roadmap will be shared in the near term.
About Spectral Capital Corporation
Founded in 2000 and based in
For more information, visit www.spectralcapital.com.
Forward-Looking Statements
This press release contains forward-looking statements (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended) concerning future events and FCCN's growth and business strategy. Words such as "expects," "will," "intends," "plans," "believes," "anticipates," "hopes," "estimates," and variations on such words and similar expressions are intended to identify forward-looking statements. Although FCCN believes that the expectations reflected in such forward-looking statements are reasonable, no assurance can be given that such expectations will prove to have been correct. These statements involve known and unknown risks and are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of FCCN. Actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, changes in FCCN's business; competitive factors in the market(s) in which FCCN operates; risks associated with operations outside the
View original content to download multimedia:https://www.prnewswire.com/news-releases/spectral-capital-appoints-dr-moshik-cohen-as-chief-technology-officer-302334874.html
SOURCE Spectral Capital Corporation
FAQ
What role will Dr. Moshik Cohen have at Spectral Capital (FCCN)?
How is Spectral Capital (FCCN) transforming its business model in 2024?
What are the key technological advantages of Dr. Cohen's plasmonic research for FCCN?
What is the strategic significance of Dr. Cohen's appointment for FCCN's future?
